Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A pan-cancer analysis of the oncogenic role of ERCC6L

22 Dec 2022

Abstract excerpt

BACKGROUND: Excision repair cross-complementation group 6 like (ERCC6L), a polo-like kinase 1 (PLK1)-interacting checkpoint helicase, confers a high risk of cancer and enhances the progression of a variety of cancers. The present investigation aimed to elucidate the pan-cancer expression patterns of ERCC6L and to examine the possibility of using this gene for patient diagnosis and prognosis. METHODS: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Genetic factors in colorectal cancer
Share to Microtubule and mitosis dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36550435
DOI: 10.1186/s12885-022-10452-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A pan-cancer analysis of the oncogenic role of ERCC6LPMID 36550435Read ↗

Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.Semantic proximity Read ↗

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and PrognosisSemantic proximity Read ↗

Potential Value of PRKDC as a Therapeutic Target and Prognostic Biomarker in Pan-CancerSemantic proximity Read ↗

Polo-like kinase 1 plays an oncogenic role in pan-cancer based on bioinformatics and biological assaysSemantic proximity Read ↗

XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysisSemantic proximity Read ↗

Pan-cancer analysis of BLM as a prognostic and immunological marker in human tumorsSemantic proximity Read ↗

Pan-Cancer Analysis of Molecular Characteristics and Oncogenic Role of PRMT5 in Human CancersSemantic proximity Read ↗

A Pan-cancer Analysis of Kelch Like Family Member 38 (KLHL38) Alterations in Human CancersSemantic proximity Read ↗

ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolutionSemantic proximity Read ↗

ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycleSemantic proximity Read ↗

Overexpression of SEZ6L2 Is associated with unfavourable prognosis and Immune infiltrates in breast cancerSemantic proximity Read ↗

ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.